Dr. Reddy's Laboratories gets EIR for API manufacturing facility in Telangana

11 Aug 2025 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from United States Food & Drug Administration (USFDA) for its API manufacturing facility (CTO 5) in Miryalaguda, Telangana, India. The USFDA has classified the inspection outcome as 'Voluntary Action Indicated (VAI)' and concluded that the inspection is officially closed under 21 CFR 20.64(d)(3).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1279.75 -1.10 (-0.09%)
19-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.20
Dr. Reddys Lab 1279.75
Cipla 1329.05
Zydus Lifesciences 902.25
Lupin 2228.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×